Diplomat Announces Executive Promotions for Fleckenstein and Rice
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Diplomat Pharmacy (DPLO) to Dispense COTELLIC + ZELBORAF Combo as Adv. Melanoma Treatment
November 11, 2015 8:16 AM ESTDiplomat Pharmacy (NYSE: DPLO) announced that it will dispense COTELLIC (cobimetinib) in combination with the BRAF inhibitor ZELBORAF (vemurafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed by surgery) or metastatic (cancer that has spread from the primary site).
The combination of COTELLIC® with ZELBORAF® helps patients with previously untreated BRAF V600 mutation-positive advanced melanoma live a median of one year (12.3 months)... More

